首页> 外文期刊>BMC Health Services Research >Use of safety-engineered devices by healthcare workers for intravenous and/or phlebotomy procedures in healthcare settings: a systematic review and meta-analysis
【24h】

Use of safety-engineered devices by healthcare workers for intravenous and/or phlebotomy procedures in healthcare settings: a systematic review and meta-analysis

机译:医护人员在医疗机构中使用安全工程设备进行静脉和/或静脉放血的程序:系统的回顾和荟萃分析

获取原文
       

摘要

Background The acquisition of needle-stick injuries (NSI) in a healthcare setting poses an occupational hazard of transmitting blood-borne pathogens from patients to healthcare workers (HCWs). The objective of this study was to systematically review the evidence about the efficacy and safety of using safety-engineered intravenous devices and safety-engineered phlebotomy devices by HCWs. Methods We included randomized and non-randomized studies comparing safety-engineered devices to conventional/standard devices that lack safety features for delivering intravenous injections and/or for blood-withdrawal procedures (phlebotomy). The outcomes of interest included NSI rates, and blood-borne infections rates among HCWs and patients. We conducted an extensive literature search strategy using the OVID interface in October 2013. We followed the standard methods for study selection and data ion. When possible, we conducted meta-analyses using a random-effects model. We used the GRADE methodology to assess the quality of evidence by outcome. Results We identified twenty-two eligible studies: Twelve assessed safety-engineered devices for intravenous procedures, five for phlebotomy procedures, and five for both. Twenty-one of those studies were observational while one was a randomized trial. All studies assessed the reduction in NSIs among HCWs. For safety-engineered intravenous devices, the pooled relative risk for NSI per HCW was 0.28 [0.13, 0.59] (moderate quality evidence). The pooled relative risk for NSI per device used or procedure performed was 0.34 [0.08,1.49] (low quality evidence). For safety-engineered phlebotomy devices, the pooled relative risk for NSI per HCW was 0.57 [0.38, 0.84] (moderate quality evidence). The pooled relative risk for NSI per device used or procedure performed was 0.53 [0.43,0.65] (moderate quality evidence). We identified no studies assessing the outcome of blood-borne infections among healthcare workers or patients. Conclusion There is moderate-quality evidence that the use of safety-engineered devices in intravenous injections and infusions, and phlebotomy (blood-drawing) procedures reduces NSI rates of HCWs.
机译:背景技术在医疗机构中获得针刺伤害(NSI)构成了将血液传播的病原体从患者传播到医护人员(HCW)的职业危害。这项研究的目的是系统地审查有关医护人员使用安全工程静脉注射装置和安全工程静脉放血装置的功效和安全性的证据。方法我们纳入了随机和非随机研究,将安全工程设备与常规/标准设备进行比较,这些常规/标准设备缺乏用于静脉注射和/或抽血程序(放血)的安全功能。感兴趣的结果包括NSI率以及HCW和患者之间的血源性感染率。 2013年10月,我们使用OVID界面进行了广泛的文献搜索策略。我们遵循标准的方法进行研究选择和数据收集。如果可能,我们使用随机效应模型进行了荟萃分析。我们使用GRADE方法论通过结果评估证据的质量。结果我们确定了22项合格研究:十二项评估了安全性的静脉内手术器械,五例进行了静脉放血手术,其中五例均进行了评估。这些研究中有二十一项是观察性研究,而一项是随机试验。所有研究均评估了医护人员中NSI的减少。对于安全设计的静脉注射器械,每HCW合并NSI的相对风险为0.28 [0.13,0.59](中等质量证据)。每个使用的设备或执行的程序所收集的NSI相对风险为0.34 [0.08,1.49](低质量证据)。对于安全设计的放血设备,每个HCW合并NSI的相对风险为0.57 [0.38,0.84](中等质量证据)。每台使用的设备或执行的程序所收集的NSI相对风险为0.53 [0.43,0.65](中等质量证据)。我们没有发现评估医护人员或患者血液传播感染结果的研究。结论有中等质量的证据表明,在静脉注射和输注以及采血(抽血)程序中使用安全工程设备会降低HCW的NSI发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号